CRVS Latest Press Releases

-- October 29, 2026 --

Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026 Globe Newswire 8:00 AM

-- September 30, 2026 --

Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa Globe Newswire 4:05 PM

-- September 3, 2026 --

Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference Globe Newswire 8:30 AM

-- August 27, 2026 --

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial Globe Newswire 7:30 AM

-- August 6, 2026 --

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results Globe Newswire 4:01 PM

-- July 30, 2026 --

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026 Globe Newswire 4:01 PM

-- June 9, 2026 --

Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes